A comprehensive review of manifestations of novel coronaviruses in the context of deadly COVID-19 global pandemic

A Gulati, C Pomeranz, Z Qamar, S Thomas… - The American journal of …, 2020 - Elsevier
Since December 2019, the global pandemic caused by the highly infectious novel
coronavirus 2019-nCoV (COVID-19) has been rapidly spreading. As of April 2020, the …

[HTML][HTML] Advances in the relationship between coronavirus infection and cardiovascular diseases

M Zhao, M Wang, J Zhang, J Ye, Y Xu, Z Wang… - Biomedicine & …, 2020 - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19) has once again aroused people's
concern about coronavirus. Seven human coronaviruses (HCoVs) have been discovered so …

[HTML][HTML] Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2

Z Yao, Z Zheng, K Wu, Z Junhua - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
Currently, we are on a global pandemic of Coronavirus disease-2019 (COVID-19) which
causes fever, dry cough, fatigue and acute respiratory distress syndrome (ARDS) that may …

[HTML][HTML] Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages

M Zhao, M Wang, J Zhang, J Gu, P Zhang, Y Xu… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Background: Information about the clinical characteristics and mortality of patients with
coronavirus disease 2019 at different ages is limited. Results: The older group had more …

[HTML][HTML] Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation

R Augustine, S Abhilash, A Nayeem, SA Salam… - Chemico-biological …, 2022 - Elsevier
The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that
causes coronavirus disease 2019 (COVID‐19), has had a dramatic negative impact on …

Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies

K Saleki, S Yaribash, M Banazadeh… - European journal of …, 2021 - Elsevier
Concern regarding coronavirus (CoV) outbreaks has stayed relevant to global health in the
last decades. Emerging COVID-19 infection, caused by the novel SARS-CoV2, is now a …

Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review

S Zhou, J Xu, C Xue, B Yang, Z Mao, ACM Ong - Renal failure, 2021 - Taylor & Francis
Objectives A meta-analysis and systematic review was conducted on kidney-related
outcomes of three recent pandemics: SARS, MERS, and COVID-19, which were associated …

[HTML][HTML] Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic …

YJ Han, KH Lee, S Yoon, SW Nam, S Ryu, D Seong… - Theranostics, 2021 - ncbi.nlm.nih.gov
Abstract Rationale: Coronavirus disease 2019 (COVID-19) has spread worldwide and poses
a threat to humanity. However, no specific therapy has been established for this disease yet …

Prevalence of diabetes mellitus and its associated unfavorable outcomes in patients with acute respiratory syndromes due to coronaviruses infection: a systematic …

I Pinedo-Torres, M Flores-Fernández… - Clinical Medicine …, 2020 - journals.sagepub.com
Introduction: Only 3 types of coronavirus cause aggressive respiratory disease in humans
(MERS-Cov, SARS-Cov-1, and SARS-Cov-2). It has been reported higher infection rates …

Clinical characteristics of two human to human transmitted coronaviruses: Corona virus disease 2019 versus middle east respiratory syndrome coronavirus

P Xu, GD Sun, ZZ Li - MedRxiv, 2020 - medrxiv.org
After the outbreak of the middle east respiratory syndrome (MERS) worldwide in 2012.
Currently, a novel human coronavirus has caused a major disease outbreak, and named …